Pinaki Biswas, Ph.D.
Affiliations: | 2007 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
organometallic and heterocyclic chemistryGoogle:
"Pinaki Biswas"Mean distance: 9.69
Parents
Sign in to add mentor| John D. Kalbfleisch | grad student | 2007 | University of Michigan (MathTree) | |
| (Pseudo observations in multi-state models and CUSUM charts for monitoring outcomes of multi-center studies.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Winthrop KL, Wouters A, Choy EH, et al. (2020) Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib. Annals of the Rheumatic Diseases |
| Charles-Schoeman C, DeMasi R, Valdez H, et al. (2019) Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology (Hoboken, N.J.) |
| Mease PJ, Kremer J, Cohen S, et al. (2018) SAT0243 Incidence of thromboembolic events in the tofacitinib rheumatoid arthritis, psoriasis, psoriatic arthritis and ulcerative colitis development programmes Annals of the Rheumatic Diseases. 77: 983-983 |
| Winthrop KL, Wouters A, Choy E, et al. (2017) The Safety and Immunogenicity of Live Zoster Vaccination in Rheumatoid Arthritis Patients Before Starting Tofacitinib: A Randomized Phase II Trial. Arthritis & Rheumatology (Hoboken, N.J.) |
| Curtis J, Yun H, FitzGerald O, et al. (2017) FRI0496 Comparing tofacitinib safety profile in patients with psoriatic arthritis in clinical studies with real-world data Annals of the Rheumatic Diseases. 76: 676-676 |
| Winthrop K, Wouters A, Choy E, et al. (2017) OP0230 The effectiveness of zoster vaccine in RA patients subsequently treated with TOFACITINIB Annals of the Rheumatic Diseases. 76: 148-149 |
| Shorr AF, Puzniak LA, Biswas P, et al. (2015) Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP). Plos One. 10: e0131932 |
| Puzniak LA, Capitano B, Biswas P, et al. (2014) Impact of patient characteristics and infection type on clinical outcomes of patients who received linezolid or vancomycin for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: a pooled data analysis. Diagnostic Microbiology and Infectious Disease. 78: 295-301 |
| Itani KM, Biswas P, Reisman A, et al. (2012) Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis. Clinical Therapeutics. 34: 1667-73.e1 |
| Schuster MG, Edwards JE, Sobel JD, et al. (2008) Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Annals of Internal Medicine. 149: 83-90 |